Sternum was founded in 2018 by a team of highly experienced research, development and business leaders. Bringing profound knowledge in embedded systems, the joint perspectives of the defender and the attacker, and an aspiration to alleviate the medical security standard, Sternum set out to build not only uncompromising innovative technology but also to create true impact.
Natali brings over 10 years of experience, both as a researcher and a team leader, in the field of offensive cyber security and software development. After graduating magna cum laude B.Sc. in Computer Science at the age of 19, as part of a special program for gifted and talented kids, Natali was handpicked to serve in IDF’s 8200 elite technology unit (the Israeli equivalent of NSA) as a low level security software engineer. Prior to founding Sternum, Natali held several security research related roles, including leading different R&D teams at Cellebrite and NSO Technologies. Natali holds an M.Sc. in Computer Science from Bar Ilan University.
CHIEF BUSINESS OFFICER
Boaz is an experienced business executive. Prior to founding Sternum, Boaz served as co-founder & CEO of ForClass until it was successfully acquired by Time To Know. Previous to that, he held the role of Chief of Business Development at the Center for Educational Technology, Israel’s market leader in innovative education. Boaz’s accomplishments include the launch of McGraw-Hill Professional’s B2B e-book library and Ivy MBA Consulting, a leading company aiding international students with their application process to top-tier business schools.
Boaz holds an MBA from the Kellogg School of Management in Northwestern University, and a double major in law and communications from Tel Aviv University, graduating both programs magna cum laude.
Lian brings with him a wealth of experience delivering large, enterprise-scale and complex products as a software team leader. Prior to founding Sternum, Lian worked as Android Researcher at NSO Technologies, creating high quality generic exploits and discovering zero-day vulnerabilities in Android devices. Lian served in IDF’s 8200 elite technology unit (the Israeli equivalent of NSA), first as a software engineer and later, as a R&D Team Leader.
HEAD OF RESEARCH
From an early age Arik's passion for security drove him to exploit anything powered by electricity. Before turning 18, Arik self learnt reverse engineering, over 10 coding languages, and finished at the top 10 of CodeGuru competition for 3 consecutive years. Arik was recruited to serve in IDF’s 8200 elite technology unit (the Israeli equivalent of NSA), where he was tasked with sensitive and complex operations in high-pressure environment. He was discharged with honors for his service at the rank of Captain.
PROF. GABI BARBASH
Prof. Barbash currently serves as Director, Bench to Bedside Program at the Weizmann Institute of Science and as Professor of Epidemiology and Preventive Medicine at the Sackler School of Medicine, Tel Aviv University. Prior to that, he was the Director General of the Tel Aviv Sourasky Medical Center. Additionally, Prof. Barbash was formerly Director General (Surgeon General) of Israel's Ministry of Health, Deputy Director of the Sheba Medical Center at Tel Hashomer, and Deputy Surgeon General of the Israel Air Force. He is a member of the Israel Medical Association, the Israel Cardiology Association and the Israel Association of Hospital Directors.
Prof. Barabash serves as a director at Elron Electronic Industries Ltd. and Poalim Ventures. He served as Chairman of the Board of Directors of Teuza Venture Capital Fund and was a member of the Scientific Committee of the Interdisciplinary Center for Technological Analysis and Forecasting at Tel-Aviv University.
Barbash has an MD from the Hebrew University of Jerusalem and holds an MA in healthcare administration from the Harvard School of Public Health.
DR. RON WAKSMAN
ADVISORY BOARD MEMBER
Ron Waksman, MD, specializes in Interventional Cardiology. Dr. Waksman is the associate director of the Division of Cardiology at MedStar Heart Institute. He is also the director of Cardiovascular Research and Advanced Education at the Heart Institute. In addition, Dr. Waksman serves as clinical professor of Medicine (Cardiology) at Georgetown University.
He is editor-in-chief of Cardiovascular Revascularization Medicine and on the editorial boards of a number of other publications, including European Heart Journal and Journal of Interventional Cardiology.
Dr. Waksman publishes extensively and has authored or co-authored more than 600 articles. He has been the principal investigator for more than 100 research trials. Dr. Waksman serves on the Cardiac Cath Laboratory Peer Review Committee at MedStar Washington Hospital Center and is a MedStar Heart Institute board member.